Circulating immunoreactive endothelin in ischemic heart disease
- 30 April 1990
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 119 (4), 801-806
- https://doi.org/10.1016/s0002-8703(05)80315-1
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Integrated cardiac, renal, and endocrine actions of endothelin.JCI Insight, 1989
- Potent selective vasoconstrictor effects of endothelin in the pig kidney in vivoActa Physiologica Scandinavica, 1988
- Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor.Proceedings of the National Academy of Sciences of the United States of America, 1988
- Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide.Proceedings of the National Academy of Sciences of the United States of America, 1988
- Effects of endothelin on the renal artery from spontaneously hypertensive and Wistar Kyoto ratsEuropean Journal of Pharmacology, 1988
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- The Role of Endothelium in the Responses of Vascular Smooth Muscle to DrugsAnnual Review of Pharmacology and Toxicology, 1984
- Role of endothelium in responses of vascular smooth muscle.Circulation Research, 1983
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980